🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease

Recruitingn/aAges 18 Years - anyAllBerner Reha Zentrum AG
NCT06027333 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients with fibrotic insterstitial lung disease (ILD) participating in inpatient rehabilitation or in outpatient pulmonary care will be invited to participate in this observational study. Patients will fill out questionnaire regarding quality of life and symptoms at baseline and follow-up (at the end of rehabilitation or after the second outpatient ILD consultation). Additionally, clinical data obtained in clinical routine or for the IIP registry will be used for this project. The aim is to assess changes in self-efficacy and quality of life over time and to establish a control cohort for a later feasibility study on a educational and self-management intervention (currently in planning).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria are: * For Berner Reha Zentrum only: Diagnosis of a FILD as major indication for pulmonary rehabilitation * For Inselspital only: Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB\_2016-01524) and agreed to further use of data for further research purpose * Age ≥ 18 years * Written informed consent Exclusion criteria are: * Cognitive inability or insufficient knowledge of project language (German) to follow informed consent or study procedures * Sarcoidosis
💊

What it tests

  • Inpatient rehabilitation (BRZ) or regular outpatient consultations (Insel)
  • Blended patient education and self-management programme (PESM)
📍

Where

2 sites
Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern
Bern, Switzerland
Berner Reha Zentrum, Rehabilitation & Sports Medicine, Insel Group, University Hospital Berne
Bern, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy